| 000 | 01923 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517000532.0 | ||
| 264 | 0 | _c20150707 | |
| 008 | 201507s 0 0 eng d | ||
| 022 | _a1573-8744 | ||
| 024 | 7 |
_a10.1007/s10928-014-9393-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Yaping | |
| 245 | 0 | 0 |
_aFLT3 and CDK4/6 inhibitors: signaling mechanisms and tumor burden in subcutaneous and orthotopic mouse models of acute myeloid leukemia. _h[electronic resource] |
| 260 |
_bJournal of pharmacokinetics and pharmacodynamics _cDec 2014 |
||
| 300 |
_a675-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzothiazoles _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase 4 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase 6 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPhenylurea Compounds _xpharmacology |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 |
_aTumor Burden _xdrug effects |
| 650 | 0 | 4 |
_afms-Like Tyrosine Kinase 3 _xantagonists & inhibitors |
| 700 | 1 | _aHsu, Cheng-Pang | |
| 700 | 1 | _aLu, Jian-Feng | |
| 700 | 1 | _aKuchimanchi, Mita | |
| 700 | 1 | _aSun, Yu-Nien | |
| 700 | 1 | _aMa, Ji | |
| 700 | 1 | _aXu, Guifen | |
| 700 | 1 | _aZhang, Yilong | |
| 700 | 1 | _aXu, Yang | |
| 700 | 1 | _aWeidner, Margaret | |
| 700 | 1 | _aHuard, Justin | |
| 700 | 1 | _aD'Argenio, David Z | |
| 773 | 0 |
_tJournal of pharmacokinetics and pharmacodynamics _gvol. 41 _gno. 6 _gp. 675-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10928-014-9393-x _zAvailable from publisher's website |
| 999 |
_c24289513 _d24289513 |
||